Global Endovascular Therapy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

Global Endovascular Therapy Devices Market, Segmentation by Product Type

The Global Endovascular Therapy Devices Market has been segmented by Product Type into Percutaneous endovascular aneurysm repair (EVAR), Fenestrated EVAR, Aortic stents, Biodegradable Stents, Self-expanding Nitinol Stents, Thoracic aortic aneurysms grafts and Others.

Percutaneous endovascular aneurysm repair (EVAR) serves as a cornerstone intervention, enabling minimally invasive treatment of abdominal aortic aneurysms (AAA) by deploying stent grafts through small groin incisions. Fenestrated EVAR provides a specialized approach for complex AAA cases, facilitating precise stent graft placement in patients with anatomical complexities. Aortic stents, particularly self-expanding nitinol stents, play a pivotal role in treating aortic stenosis and providing structural reinforcement to weakened arterial walls.

The market also features innovative solutions such as biodegradable stents, offering temporary artery support while gradually dissolving over time, thereby reducing long-term complications associated with permanent implants. Moreover, thoracic aortic aneurysm grafts deliver targeted treatment for thoracic aortic aneurysms, offering personalized solutions for specific patient needs. Other devices in the market encompass a diverse array of interventions, including embolization coils, atherectomy devices, and drug-eluting stents, catering to a wide range of vascular pathologies and treatment preferences.

Continuous advancements in endovascular therapy devices are propelled by ongoing research and development initiatives focused on improving treatment outcomes, minimizing procedural complications, and enhancing patient well-being. Manufacturers are dedicated to innovating stent design, material composition, and delivery systems to optimize device performance and patient safety. Additionally, the growing adoption of minimally invasive techniques and the rising demand for outpatient procedures contribute to the increasing utilization of endovascular therapy devices worldwide. Overall, the market's diversity and innovation underscore its crucial role in managing vascular diseases and propelling advancements in interventional cardiology and radiology.

Global Endovascular Therapy Devices Market, Segmentation by Procedures

The Global Endovascular Therapy Devices Market has been segmented by Procedures into Balloon Angioplasty, Angioplasty with Stent Placement, Drug-Eluting Stents (DES), Renal Artery Angioplasty and Stenting, Carotid Artery Stenting, Transfemoral Carotid Artery Stenting, Transcarotid Artery Revascularization, Intravascular Brachytherapy, Atherectomy and Thrombolysis.

Common procedures include balloon angioplasty, which utilizes a balloon-tipped catheter to widen narrowed or blocked blood vessels, often complemented by stent placement to maintain artery patency. Drug-eluting stents (DES) release medication to prevent restenosis, enhancing treatment outcomes and reducing the need for repeat interventions.

Renal artery angioplasty and stenting target renal artery stenosis, a condition linked to high blood pressure and kidney damage, while carotid artery stenting aims to prevent strokes by opening narrowed carotid arteries. Emerging techniques such as transfemoral carotid artery stenting and transcarotid artery revascularization offer alternative approaches, expanding treatment options for patients and healthcare providers alike.

Intravascular brachytherapy delivers radiation during angioplasty to prevent restenosis in coronary arteries, while atherectomy involves plaque removal using specialized devices, offering an alternative for severe arterial blockages. Thrombolysis employs medications to dissolve blood clots, restoring blood flow in occluded arteries. These procedures highlight the versatility and effectiveness of endovascular therapy devices in treating a wide range of vascular conditions, providing patients with less invasive alternatives to traditional surgical methods.

Global Endovascular Therapy Devices Market, Segmentation by Application

The Global Endovascular Therapy Devices Market has been segmented by Application into Pulmonary, Vascular, Cardiology, Surgery, Neurology and Radiology.

In pulmonary applications, these devices target pulmonary embolism and hypertension, among other lung-related vascular conditions. Through procedures like pulmonary artery angioplasty and stent placement, endovascular therapy devices facilitate improved blood flow, alleviating symptoms and enhancing the quality of life for patients with pulmonary vascular diseases.

Vascular applications encompass interventions for peripheral artery disease (PAD) and deep vein thrombosis (DVT), utilizing devices such as stents and angioplasty balloons to restore blood flow and prevent complications. These minimally invasive approaches offer advantages over traditional surgeries, reducing recovery times and postoperative risks. Within cardiology, endovascular therapy devices are instrumental in treating conditions like coronary artery disease and heart valve disorders through procedures like coronary angioplasty and transcatheter aortic valve replacement (TAVR), providing effective solutions for heart-related ailments.

Endovascular therapy devices find utility in surgical, neurological, and radiological applications, facilitating procedures such as aneurysm repair, stroke treatment, and embolization. This versatility underscores the significance of these devices across diverse medical specialties. As advancements in technology and research continue, the global market for endovascular therapy devices is poised for further growth, offering new opportunities to enhance patient care and treatment outcomes across the medical spectrum.

Global Endovascular Therapy Devices Market, Segmentation by End User Type

The Global Endovascular Therapy Devices Market has been segmented by End User Type into Hospitals, Clinics and Research Institutes.

Hospitals stand out as the largest segment, wielding substantial influence due to their comprehensive infrastructure and specialized medical staff. They serve as primary centers for a broad spectrum of endovascular procedures, addressing the increasing prevalence of cardiovascular and peripheral vascular diseases. The preference for minimally invasive treatments further fuels the demand for endovascular therapy devices in hospital settings.

Clinics, particularly outpatient facilities, emerge as vital players in the endovascular therapy landscape, especially amid the trend towards outpatient care models. Offering accessible and convenient settings, clinics facilitate minimally invasive procedures like angioplasty and stent placement with shorter recovery periods and reduced hospitalization. As the shift towards office-based endovascular interventions gains momentum, clinics anticipate heightened adoption of specialized devices and technologies tailored for outpatient settings.

Research institutes contribute significantly to advancing endovascular therapy devices through scientific exploration, clinical trials, and technological innovation. Collaborating closely with manufacturers and healthcare providers, these institutes drive the development and evaluation of new treatment modalities while refining existing technologies. Their rigorous preclinical and clinical studies validate the safety and efficacy of endovascular devices, enabling their commercialization and widespread acceptance. Moreover, research institutes play a crucial role in educating future healthcare professionals and fostering interdisciplinary collaboration within the realm of endovascular therapy.

Drivers:

• Advancements in Endovascular Technologies
• Increasing Prevalence of Cardiovascular Diseases

• Growing Aging Population: The expanding aging population globally is a significant contributor to the growth of the endovascular therapy devices market. With age, individuals become more prone to cardiovascular and peripheral vascular diseases, attributed to factors such as atherosclerosis and arterial stiffness. As a result, the demand for effective treatment options, including endovascular therapies, rises among the elderly demographic. This demographic shift presents a substantial growth opportunity for manufacturers operating in the endovascular therapy devices market.

  Elderly individuals often experience a higher incidence of cardiovascular and peripheral vascular conditions, necessitating advanced treatment modalities to address their healthcare needs. Endovascular therapies offer minimally invasive solutions for managing these age-related conditions, providing patients with effective treatment options that minimize risks and recovery times. As the aging population continues to grow, the demand for endovascular therapy devices is anticipated to escalate, driving market expansion and innovation in treatment technologies.

  Manufacturers of endovascular therapy devices stand to benefit significantly from the increasing demand generated by the aging population. By developing and offering innovative and tailored solutions that address the specific needs of elderly patients, companies can capitalize on this demographic trend. Moreover, as healthcare systems focus on improving care for aging populations, there is a growing emphasis on adopting advanced medical technologies, further stimulating the demand for endovascular therapy devices among elderly patients globally.

Restraints:

• High Cost of Endovascular Procedures
• Complexity of Endovascular Interventions

• Risk of Complications and Adverse Events: Endovascular procedures come with inherent risks of complications and adverse events, posing challenges for both patients and physicians considering these interventions. Potential risks include vascular injury, thrombosis, and issues related to the implanted devices. These risks may dissuade patients and physicians from choosing endovascular treatments, especially when alternative modalities are available. Addressing these concerns and mitigating risks is paramount to enhancing the safety profile of endovascular therapy devices and fostering greater confidence among stakeholders.

  To mitigate the risks associated with endovascular procedures, advancements in device design, procedural techniques, and patient selection criteria are essential. Improvements in device design focus on enhancing the durability, biocompatibility, and functionality of endovascular devices to minimize adverse events. Additionally, refining procedural techniques through training and standardization helps ensure the safe and effective delivery of endovascular therapies. Furthermore, careful patient selection criteria, considering factors such as comorbidities and anatomical considerations, can help optimize treatment outcomes and minimize risks.

  Enhancing the safety profile of endovascular therapy devices not only benefits patients but also bolsters the confidence of healthcare providers in recommending these interventions. By prioritizing safety and implementing measures to mitigate risks, manufacturers and healthcare professionals can promote the wider adoption of endovascular therapies. Ultimately, these efforts contribute to improving patient outcomes and advancing the field of endovascular medicine.

Opportunities:

• Technological Innovations in Device Design
• Expansion into Emerging Markets

• Shift towards Outpatient and Office-based Procedures: The transition towards outpatient and office-based endovascular procedures signifies a significant shift in healthcare delivery, presenting promising opportunities for market growth. By moving away from traditional inpatient settings, healthcare providers can lower healthcare costs and enhance patient convenience. The adoption of minimally invasive endovascular interventions in ambulatory settings offers numerous advantages, including shorter recovery times, decreased complication rates, and optimized utilization of healthcare resources. This shift aligns with the growing emphasis on value-based care and patient-centered approaches, driving the demand for office-based endovascular therapies.

  Performing endovascular procedures in outpatient and office-based settings offers several benefits for both patients and healthcare providers. Patients experience shorter recovery times and reduced hospital stays, leading to enhanced comfort and convenience. Moreover, lower complication rates associated with minimally invasive procedures contribute to improved patient satisfaction and outcomes. Healthcare providers benefit from optimized resource utilization and streamlined workflows, enabling them to deliver high-quality care efficiently. As the trend towards outpatient and office-based procedures continues to gain traction, manufacturers have the opportunity to develop specialized devices and delivery systems tailored to meet the specific needs of these settings.

  Manufacturers can capitalize on the increasing demand for office-based endovascular therapies by developing innovative solutions optimized for outpatient settings. Specialized devices and delivery systems designed for use in ambulatory environments can enhance procedural efficiency and patient outcomes. By offering products that cater to the unique requirements of office-based procedures, manufacturers can address emerging market needs and differentiate themselves in a competitive landscape. This strategic approach enables manufacturers to position themselves as leaders in providing solutions that support the evolving healthcare delivery model focused on outpatient care.